Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Take part in our research

enquires@ndcn.ox.ac.uk

What's new

Oxford is top recruiter to drug resitant epilepsy study

Oxford is top recruiter to drug-resitant epilepsy study

The Oxford Epilepsy Research Group is at the forefront of some potentially ground-breaking work with patients who have drug-resistant epilepsy. Epilepsy affects over 50 million people worldwide and nearly one in three people with epilepsy are resistant to current drugs.

Advances made in understanding how eye movements are affected by medication in parkinsons

Advances made in understanding how eye movements are affected by medication in Parkinson's

Our Neurometrology Group has published findings from its OxQUIP study looking at how eye movements are affected by medication in Parkinson's.

Prize for work on gene therapy for retinal diseases

Prize for work on gene therapy for retinal diseases

Dr Kanmin Xue has won the Ruskell Medal from the Worshipful Company of Spectacle Makers

Masonic charitable foundation fund studentship at centre for the prevention of stroke and dementia

Masonic Charitable Foundation Fund Studentship at Centre for the Prevention of Stroke and Dementia

The charity has provided £126K of funding for one 3-year clinical research fellowship starting in January 2020.

AT A GLANCE

Infographic

Events

Athena swan silver
Stonewall diversity champion